Nonadrenergic imidazoline binding sites and amine oxidase activities in fat cells.
Carpéné
C
C
Institut National de la Santé et de la Recherche Médicale, (INSERM U 317), Institut Louis Bugnard, Université Paul SABATIER, C.H.U. Rangueil, Toulouse, France.
Marti
L
L
Hudson
A
A
Lafontan
M
M
D017667:Adipocytes / Q000201:enzymology / Q000378:metabolism*; D058647:Adrenergic alpha-2 Receptor Agonists; D058669:Adrenergic alpha-2 Receptor Antagonists; D006631:Amine Oxidase (Copper-Containing); D000818:Animals; D001665:Binding Sites; D004146:Dioxanes / Q000037:antagonists & inhibitors / Q000378:metabolism; D006801:Humans; D019329:Idazoxan; D007093:Imidazoles / Q000037:antagonists & inhibitors / Q000378:metabolism*; D008066:Lipolysis; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D010084:Oxidation-Reduction; D000587:Oxidoreductases Acting on CH-NH Group Donors / Q000378:metabolism*; D018341:Receptors, Adrenergic, alpha-2 / Q000378:metabolism
D058647:Adrenergic alpha-2 Receptor Agonists; D058669:Adrenergic alpha-2 Receptor Antagonists; D004146:Dioxanes; D007093:Imidazoles; D008996:Monoamine Oxidase Inhibitors; D018341:Receptors, Adrenergic, alpha-2; D006631:Amine Oxidase (Copper-Containing); D000587:Oxidoreductases Acting on CH-NH Group Donors; D019329:Idazoxan